• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

优化 COVID-19 疫苗在荷兰的分配:基于数据的优先级排序。

Optimal vaccine allocation for COVID-19 in the Netherlands: A data-driven prioritization.

机构信息

Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.

Center for Marine Environmental Studies (CMES), Ehime University, Ehime, Japan.

出版信息

PLoS Comput Biol. 2021 Dec 13;17(12):e1009697. doi: 10.1371/journal.pcbi.1009697. eCollection 2021 Dec.

DOI:10.1371/journal.pcbi.1009697
PMID:34898617
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8699630/
Abstract

For the control of COVID-19, vaccination programmes provide a long-term solution. The amount of available vaccines is often limited, and thus it is crucial to determine the allocation strategy. While mathematical modelling approaches have been used to find an optimal distribution of vaccines, there is an excessively large number of possible allocation schemes to be simulated. Here, we propose an algorithm to find a near-optimal allocation scheme given an intervention objective such as minimization of new infections, hospitalizations, or deaths, where multiple vaccines are available. The proposed principle for allocating vaccines is to target subgroups with the largest reduction in the outcome of interest. We use an approximation method to reconstruct the age-specific transmission intensity (the next generation matrix), and express the expected impact of vaccinating each subgroup in terms of the observed incidence of infection and force of infection. The proposed approach is firstly evaluated with a simulated epidemic and then applied to the epidemiological data on COVID-19 in the Netherlands. Our results reveal how the optimal allocation depends on the objective of infection control. In the case of COVID-19, if we wish to minimize deaths, the optimal allocation strategy is not efficient for minimizing other outcomes, such as infections. In simulated epidemics, an allocation strategy optimized for an outcome outperforms other strategies such as the allocation from young to old, from old to young, and at random. Our simulations clarify that the current policy in the Netherlands (i.e., allocation from old to young) was concordant with the allocation scheme that minimizes deaths. The proposed method provides an optimal allocation scheme, given routine surveillance data that reflect ongoing transmissions. This approach to allocation is useful for providing plausible simulation scenarios for complex models, which give a more robust basis to determine intervention strategies.

摘要

为了控制 COVID-19,疫苗接种计划提供了一种长期解决方案。可用疫苗的数量通常是有限的,因此确定分配策略至关重要。虽然已经使用数学模型方法来寻找疫苗的最佳分配,但需要模拟的可能分配方案数量过多。在这里,我们提出了一种算法,用于在存在多种疫苗的情况下,根据干预目标(例如,将新感染、住院或死亡人数降至最低)找到接近最优的分配方案。我们分配疫苗的原则是针对具有最大预期效果的亚组进行靶向。我们使用近似方法重建特定年龄的传播强度(下一代矩阵),并根据观察到的感染发生率和感染强度来表示为每个亚组接种疫苗的预期效果。该方法首先在模拟疫情中进行评估,然后应用于荷兰 COVID-19 的流行病学数据。我们的结果揭示了最优分配方案如何取决于感染控制的目标。在 COVID-19 的情况下,如果我们希望将死亡人数降至最低,那么针对死亡人数进行优化的最佳分配策略对于降低其他结果(如感染人数)并不有效。在模拟疫情中,针对特定结果进行优化的分配策略优于其他策略,例如从年轻到年老、从年老到年轻和随机分配。我们的模拟结果表明,荷兰当前的政策(即从年老到年轻的分配)与最小化死亡人数的分配方案是一致的。该方法提供了一种最优分配方案,前提是有反映正在进行的传播的常规监测数据。这种分配方法对于为复杂模型提供合理的模拟场景很有用,这为确定干预策略提供了更可靠的基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40b5/8699630/0ac872a336ac/pcbi.1009697.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40b5/8699630/adb2dfe7a822/pcbi.1009697.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40b5/8699630/6e5b2b23e9c1/pcbi.1009697.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40b5/8699630/0ac872a336ac/pcbi.1009697.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40b5/8699630/adb2dfe7a822/pcbi.1009697.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40b5/8699630/6e5b2b23e9c1/pcbi.1009697.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40b5/8699630/0ac872a336ac/pcbi.1009697.g003.jpg

相似文献

1
Optimal vaccine allocation for COVID-19 in the Netherlands: A data-driven prioritization.优化 COVID-19 疫苗在荷兰的分配:基于数据的优先级排序。
PLoS Comput Biol. 2021 Dec 13;17(12):e1009697. doi: 10.1371/journal.pcbi.1009697. eCollection 2021 Dec.
2
Optimal SARS-CoV-2 vaccine allocation using real-time attack-rate estimates in Rhode Island and Massachusetts.利用罗德岛和马萨诸塞州实时发病率估计值优化 SARS-CoV-2 疫苗分配。
BMC Med. 2021 Jul 13;19(1):162. doi: 10.1186/s12916-021-02038-w.
3
Time-varying optimization of COVID-19 vaccine prioritization in the context of limited vaccination capacity.在有限的疫苗接种能力背景下,COVID-19 疫苗接种的时变优化。
Nat Commun. 2021 Aug 3;12(1):4673. doi: 10.1038/s41467-021-24872-5.
4
Modelling direct and herd protection effects of vaccination against the SARS-CoV-2 Delta variant in Australia.建模澳大利亚针对 SARS-CoV-2 Delta 变异株的疫苗接种对直接和群体保护的效果。
Med J Aust. 2021 Nov 1;215(9):427-432. doi: 10.5694/mja2.51263. Epub 2021 Oct 11.
5
SARS-CoV-2 vaccines for all but a single dose for COVID-19 survivors.除一剂疫苗外,为新冠病毒疾病幸存者接种严重急性呼吸综合征冠状病毒2型疫苗。
EBioMedicine. 2021 Jun;68:103401. doi: 10.1016/j.ebiom.2021.103401. Epub 2021 May 26.
6
Vaccine optimization for COVID-19: Who to vaccinate first?2019冠状病毒病疫苗优化:优先接种对象为谁?
Sci Adv. 2021 Feb 3;7(6). doi: 10.1126/sciadv.abf1374. Print 2020 Feb.
7
Comparing COVID-19 vaccine allocation strategies in India: A mathematical modelling study.比较印度的 COVID-19 疫苗分配策略:一项数学建模研究。
Int J Infect Dis. 2021 Feb;103:431-438. doi: 10.1016/j.ijid.2020.12.075. Epub 2020 Dec 31.
8
Evaluation of Vaccination Strategies to Compare Efficient and Equitable Vaccine Allocation by Race and Ethnicity Across Time.评估疫苗接种策略,以比较种族和族裔在不同时间的高效和公平疫苗分配。
JAMA Health Forum. 2021 Aug 20;2(8):e212095. doi: 10.1001/jamahealthforum.2021.2095. eCollection 2021 Aug.
9
Developing a Framework for Pandemic COVID-19 Vaccine Allocation: a Modified Delphi Consensus Study in Korea.制定大流行 COVID-19 疫苗分配框架:韩国的一项改良德尔菲共识研究。
J Korean Med Sci. 2021 Jun 14;36(23):e166. doi: 10.3346/jkms.2021.36.e166.
10
The role of childrens' vaccination for COVID-19-Pareto-optimal allocations of vaccines.儿童接种 COVID-19 疫苗的作用-疫苗的帕累托最优分配。
PLoS Comput Biol. 2022 Feb 25;18(2):e1009872. doi: 10.1371/journal.pcbi.1009872. eCollection 2022 Feb.

引用本文的文献

1
Identifying the main drivers of transmission in the early phase of the COVID-19 pandemic in Portugal.确定葡萄牙新冠疫情早期传播的主要驱动因素。
Sci Rep. 2024 Dec 28;14(1):30689. doi: 10.1038/s41598-024-76604-6.
2
Predictive modelling of the effectiveness of vaccines against COVID-19 in Bogotá: Methodological innovation involving different variants and computational optimisation efficiency.波哥大针对新冠病毒疫苗有效性的预测建模:涉及不同变体和计算优化效率的方法创新
Heliyon. 2024 Oct 23;10(21):e39725. doi: 10.1016/j.heliyon.2024.e39725. eCollection 2024 Nov 15.
3
Patients' perspectives on ethical principles to fairly allocate scarce surgical resources during the COVID-19 pandemic in the Netherlands: a Q-methodology study.

本文引用的文献

1
Fractionation of COVID-19 vaccine doses could extend limited supplies and reduce mortality.分剂接种新冠疫苗可延长有限的供应并降低死亡率。
Nat Med. 2021 Aug;27(8):1321-1323. doi: 10.1038/s41591-021-01440-4.
2
Controlling the pandemic during the SARS-CoV-2 vaccination rollout.在 SARS-CoV-2 疫苗接种推广期间控制疫情。
Nat Commun. 2021 Jun 16;12(1):3674. doi: 10.1038/s41467-021-23938-8.
3
Modeling vaccination rollouts, SARS-CoV-2 variants and the requirement for non-pharmaceutical interventions in Italy.意大利疫苗接种推广、新冠病毒变异株及非药物干预措施需求的建模
荷兰 COVID-19 大流行期间公平分配稀缺外科资源的伦理原则:一项 Q 方法学研究 。
BMJ Open. 2024 Sep 23;14(9):e086681. doi: 10.1136/bmjopen-2024-086681.
4
Learning from the COVID-19 pandemic: A systematic review of mathematical vaccine prioritization models.从新冠疫情中学习:数学疫苗优先排序模型的系统综述
Infect Dis Model. 2024 May 15;9(4):1057-1080. doi: 10.1016/j.idm.2024.05.005. eCollection 2024 Dec.
5
Learning from the COVID-19 pandemic: a systematic review of mathematical vaccine prioritization models.从新冠疫情中学习:数学疫苗优先级模型的系统综述
medRxiv. 2024 Mar 7:2024.03.04.24303726. doi: 10.1101/2024.03.04.24303726.
6
Age-specific transmission dynamics of SARS-CoV-2 during the first 2 years of the pandemic.新冠疫情头两年期间新冠病毒的年龄特异性传播动态。
PNAS Nexus. 2024 Jan 31;3(2):pgae024. doi: 10.1093/pnasnexus/pgae024. eCollection 2024 Feb.
7
Covid19Vaxplorer: A free, online, user-friendly COVID-19 vaccine allocation comparison tool.Covid19Vaxplorer:一款免费、在线且用户友好的新冠疫苗分配比较工具。
PLOS Glob Public Health. 2024 Jan 22;4(1):e0002136. doi: 10.1371/journal.pgph.0002136. eCollection 2024.
8
Predictive models for health outcomes due to SARS-CoV-2, including the effect of vaccination: a systematic review.预测 SARS-CoV-2 导致的健康结果的模型,包括疫苗接种的效果:系统评价。
Syst Rev. 2024 Jan 16;13(1):30. doi: 10.1186/s13643-023-02411-1.
9
Impact of vaccine measures on the transmission dynamics of COVID-19.疫苗措施对 COVID-19 传播动力学的影响。
PLoS One. 2023 Aug 25;18(8):e0290640. doi: 10.1371/journal.pone.0290640. eCollection 2023.
10
The daily updated Dutch national database on COVID-19 epidemiology, vaccination and sewage surveillance.每日更新的荷兰 COVID-19 流行病学、疫苗接种和污水监测国家数据库。
Sci Data. 2023 Jul 20;10(1):469. doi: 10.1038/s41597-023-02232-w.
Nat Med. 2021 Jun;27(6):993-998. doi: 10.1038/s41591-021-01334-5. Epub 2021 Apr 16.
4
Dynamic prioritization of COVID-19 vaccines when social distancing is limited for essential workers.在社交距离对基本工人有限时,对 COVID-19 疫苗进行动态优先级排序。
Proc Natl Acad Sci U S A. 2021 Apr 20;118(16). doi: 10.1073/pnas.2025786118.
5
COVID-19 vaccines for the European region: an unprecedented challenge.欧洲地区的新冠疫苗:一项前所未有的挑战。
Lancet. 2021 May 8;397(10286):1689-1691. doi: 10.1016/S0140-6736(21)00709-1. Epub 2021 Mar 25.
6
Associations Between Measures of Social Distancing and Severe Acute Respiratory Syndrome Coronavirus 2 Seropositivity: A Nationwide Population-based Study in the Netherlands.社会隔离措施与严重急性呼吸综合征冠状病毒 2 血清阳性率之间的关联:荷兰全国范围内的基于人群的研究。
Clin Infect Dis. 2021 Dec 16;73(12):2318-2321. doi: 10.1093/cid/ciab264.
7
Vaccination and non-pharmaceutical interventions for COVID-19: a mathematical modelling study.2019冠状病毒病的疫苗接种与非药物干预措施:一项数学建模研究
Lancet Infect Dis. 2021 Jun;21(6):793-802. doi: 10.1016/S1473-3099(21)00143-2. Epub 2021 Mar 18.
8
The potential health and economic value of SARS-CoV-2 vaccination alongside physical distancing in the UK: a transmission model-based future scenario analysis and economic evaluation.英国新冠病毒疫苗接种与保持社交距离相结合的潜在健康和经济价值:基于传播模型的未来情景分析与经济评估
Lancet Infect Dis. 2021 Jul;21(7):962-974. doi: 10.1016/S1473-3099(21)00079-7. Epub 2021 Mar 18.
9
An interactive website tracking COVID-19 vaccine development.一个追踪新冠疫苗研发情况的交互式网站。
Lancet Glob Health. 2021 May;9(5):e590-e592. doi: 10.1016/S2214-109X(21)00043-7. Epub 2021 Mar 2.
10
The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Janssen COVID-19 Vaccine - United States, February 2021.美国免疫实践咨询委员会关于使用杨森新冠疫苗的临时建议 - 2021年2月
MMWR Morb Mortal Wkly Rep. 2021 Mar 5;70(9):329-332. doi: 10.15585/mmwr.mm7009e4.